|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.7 NGN | 0.00% |
|
-8.11% | -12.37% |
Neimeth International Pharmaceuticals Plc reported earnings results for the fourth quarter ended September 30, 2022. For the fourth quarter, the company reported sales was NGN 875.99 million compared to NGN 1,055.37 million a year ago. Net income was NGN 23.99 million compared to NGN 185.75 million a year ago.
Basic earnings per share from continuing operations was NGN 0.01 compared to NGN 0.1 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.37% | 4.95M | |
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.21% | 168B |
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC 